Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSoftcat Regulatory News (SCT)

Share Price Information for Softcat (SCT)

Share Price is delayed by 15 minutes
Get Live Data
1,813.00    35.00 (1.97%)
Bid:
1,811.00
Ask:
1,813.00
Spread: 2.00 (0.11%)
Market Cap: £3.56b
SCT Live PriceLast checked at - London Stock Exchange

Intraday Softcat Share Chart

Directorate Change

15 Oct 2008 13:51

RNS Number : 9186F
Screen Technology Group plc
15 October 2008
 



15 October 2008

Screen Technology Group plc

("Screen Technology" or the "Company")

Directorate Change

Screen Technology announces that Tom Jarman has stepped down as Chief Executive Officer. Tom has been succeeded by Chris Hanson, Screen Technology's CFO, who has today been appointed a director of the Company.

Tom has agreed to remain an employee of the Group until early 2009 to ensure a smooth transition.

Tom has been a director of Screen Technology for almost seven years and has been CEO since 2006, during which time he has made a significant contribution to the business. Tom wishes to spend more time with his family in Gloucestershire and he and the Board agreed that it is the right time for new leadership to take the business forward.

David Christopher Hanson (50) has been Screen Technology's CFO since June 2007. Chris was previously Finance Director and then Chief Operating Officer at Cardpoint plc. He has extensive experience as a Finance Director with a number of other public companies including Parkland Group plc and JWE Telecom plc. He qualified as an accountant in 1982 and spent 13 years with KPMG.

Chris has a beneficial and family interest in 3,181,818 Screen Technology ordinary shares representing approximately 1.56 per cent of the share capital of the Company. He also has warrants to acquire a further 11,484,848 Screen Technology ordinary shares at a price of 0.66 per share.

The Board is also pleased to announce two new appointments to the Board of Screen Technology Limited, the Company's main trading subsidiary. Campbell Cromar has been appointed as Managing Director and Paul Bayley as Sales Director. Campbell is currently Chief Operating Officer of Screen Technology Limited and has 22 years experience in the digital screen market. Paul, a founder member of the Itrans team, has been with the business for 12 years and was previously Chief Technology Officer. 

Peter Smyth, Screen Technology Chairman, commented, "I would like to thank Tom for his contribution, particularly during the refinancing which took place earlier this year, and I am pleased to announce Chris as his successor. I am also very pleased to announce the changes that we have made at Screen Technology Limited which I believe will allow the business to build on the progress made to date."

Screen Technology Group plc

Peter Smyth

Chris Hanson

Tel: 01353 660250

Charles Stanley Securities 

Nominated Adviser

Russell Cook / Carl Holmes

Tel: 020 7149 6000

Chris Hanson Current Directorships

None

Chris Hanson Previous Directorships

Pharmetiq plc

Cardpoint plc

Chris Hanson was a director of John Brunton plc when it was placed into administrative receivership in July 1993. He was initially seconded from KPMG to John Brunton plc and later became a director, with a view to assisting with a turn around of the business. When it became apparent that this was not possible, John Brunton plc was placed into administrative receivership owing approximately £935,000.

There are no other details required to be disclosed under paragraph (g) of Schedule 2 of the AIM Rules.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAGUGUAUUPRGPA
Date   Source Headline
20th Jan 20259:34 amRNSHolding(s) in Company
17th Jan 20253:51 pmRNSDirector/PDMR Shareholding
8th Jan 20252:02 pmRNSDirector/PDMR Shareholding
2nd Jan 202511:52 amRNSTotal Voting Rights
12th Dec 20243:07 pmRNSDirector/PDMR Shareholding
10th Dec 20243:40 pmRNSDirector/PDMR Shareholding
10th Dec 202412:54 pmRNSResult of AGM
4th Dec 20242:22 pmRNSDirector/PDMR Shareholding
2nd Dec 202412:11 pmRNSTotal Voting Rights
26th Nov 202410:47 amRNSDirector/PDMR Shareholding
26th Nov 202410:45 amRNSDirector/PDMR Shareholding
20th Nov 20247:00 amRNSQ1 2025 Trading Update
18th Nov 20241:55 pmRNSBlock listing Interim Review
11th Nov 20243:31 pmRNSDirector/PDMR Shareholding
1st Nov 20242:36 pmRNSAnnual Financial Report
1st Nov 20249:19 amRNSTotal Voting Rights
24th Oct 20247:00 amRNSFinal Results
14th Oct 202410:01 amRNSHolding(s) in Company
8th Oct 20243:06 pmRNSDirector/PDMR Shareholding
7th Oct 20242:28 pmRNSNotice of Results
1st Oct 20242:37 pmRNSTotal Voting Rights
26th Sep 20249:34 amRNSHolding(s) in Company
16th Sep 20249:41 amRNSHolding(s) in Company
13th Sep 202410:21 amRNSHolding(s) in Company
11th Sep 20249:26 amRNSDirector/PDMR Shareholding
22nd Aug 20249:30 amRNSHolding(s) in Company
9th Aug 202410:45 amRNSDirector/PDMR Shareholding
1st Aug 202410:15 amRNSTotal Voting Rights
24th Jul 20249:32 amRNSHolding(s) in Company
9th Jul 202412:29 pmRNSDirector/PDMR Shareholding
1st Jul 20249:17 amRNSTotal Voting Rights
10th Jun 202412:53 pmRNSChange of Adviser
10th Jun 202411:24 amRNSDirector/PDMR Shareholding
3rd Jun 20249:26 amRNSTotal Voting Rights
28th May 20247:00 amRNSQ3 2024 Trading Update
23rd May 202410:02 amRNSBlock listing Interim Review
10th May 20242:25 pmRNSDirector/PDMR Shareholding
9th May 20243:09 pmRNSDirector/PDMR Shareholding
1st May 202410:50 amRNSTotal Voting Rights
9th Apr 20249:45 amRNSDirector/PDMR Shareholding
2nd Apr 20249:13 amRNSTotal Voting Rights
26th Mar 20241:00 pmRNSHolding(s) in Company
26th Mar 20247:00 amRNSHalf-year Report
15th Mar 20242:45 pmRNSDirector/PDMR Shareholding
4th Mar 20247:00 amRNSNotice of Results
1st Mar 20242:28 pmRNSHolding(s) in Company
1st Mar 202410:47 amRNSTotal Voting Rights
8th Feb 20249:34 amRNSDirector/PDMR Shareholding
1st Feb 20249:49 amRNSTotal Voting Rights
30th Jan 20249:58 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.